Abstract:Death receptor 3 (DR3) (a.k.a. tumor necrosis factor receptor superfamily 25) plays a key role in the immune system by activating nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway. Here we present the crystal structures of human and mouse DR3 intracellular death domain (DD) at 2.7 and 2.5 angstrom resolutions, respectively. The mouse DR3 DD adopts a classical six-helix bundle structure while human DR3 DD displays an extended fold. Though there is one-amino-acid difference in the linker between maltose-binding protein (MBP) tag and DR3 DD, according to our self-interaction analysis, the hydrophobic interface discovered in MBP-hDR3 DD crystal structure is responsible for both hDR3 DD and mDR3 DD homotypic interaction. Furthermore, our biochemical analysis indicates that the sequence variation between human and mouse DR3 DD does not affect its structure and function. Small-angle X-ray scattering analysis shows the averaged solution structures of both human and mouse MBP-DR3 DD are the combination of different conformations with different proportion. Through switching to the open conformation, DR3 DD could improve the interaction with downstream element TNFR-associated death domain (TRADD). Here we propose an activation-dependent structural rearrangement model: the DD region is folded as the six-helix bundles in the resting state, while upon extracellular ligand engagement, it switches to the open conformation, which facilitates its self-association and the recruitment of TRADD. Our results provide detailed insights into the architecture of DR3 DD and the molecular mechanism of activation. Databases All refined structure coordinates as well as the corresponding structure factors have been deposited in the PDB under the accession codes , , , , .

Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.

Crystal structures of FasL:DcR3 and LIGHT:DcR3 complexes reveal the molecular basis for the broad specificity of DcR3 (CCR5P.255)

The Fas Ligand As a Cell Death Factor and Signal Transducer

Considering Fas ligand as a target for therapy.

Activation‐dependent FasL Expression in T Lymphocytes and Natural Killer Cells

The Adaptor Protein Nck Interacts with Fas Ligand: Guiding the Death Factor to the Cytotoxic Immunological Synapse

Slowly getting a clue on CD95 ligand biology.

Regulation of FasL Expression: A SH3 Domain Containing Protein Family Involved in the Lysosomal Association of FasL

The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors

Structure Determination of Human Fas Apoptosis Inhibitory Molecule and Identification of the Critical Residues Linking the Interdomain Interaction to the Anti-Apoptotic Activity.

Exploration and blockade of the decoy strategy: crystal structure of the LIGHT:DcR3 complex and rational design of DcR3 antagonists

Crystallization and Preliminary X-ray Crystallographic Studies of Human FAIM Protein.

Inhibition of Fas-mediated Apoptosis by the B Cell Antigen Receptor Through C-Flip.

FasL Associated Factor SH3P12 and Its Potential Role in the Regulation of FasL Expression

Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly.

Crystal Structure and Activation Mechanism of DR3 Death Domain.

Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

Deciphering DED assembly mechanisms in FADD-procaspase-8-cFLIP complexes regulating apoptosis

Apoptosis and Potential Immunoregulation Mediated by Fas Molecular

Production, purification and cytotoxity of soluble human Fas ligand expressed by Escherichia coli and Dictyostelium discoideum